Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
94
datasets available to search
ShareScore release 0.7.1
Dataset results
94 results for “clindamycin”
A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Ac
ClinicalTrials.gov study NCT02210689. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Genome-scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin resistant parasites
GEO Series GSE22861. Plasmodium falciparum. 16 samples. Type: Genome variation profiling by genome tiling array.
Antibacterial and osteogenic activities of clindamycin-releasing mesoporous ailica/carboxymethyl chitosan composite hydrogels
<p>Conventional treatment of jaw bone infection is often ineffective to control bacterial infection and enhance bone regeneration. Biodegradable composite hydrogels comprised carboxymethyl chitosan (CMCS) and clindamycin (CDM)-loaded mesoporous silica nanoparticles (MCM-41), possessing dual antibacterial activity and osteogenic potency, were developed in the present study. CDM was successfully loaded into both untreated and plasma-treated MCM-41 nanoparticles, denoted as (p)-MCM-41, followed by the incorporation of each of CDM-loaded (p)-MCM-41 into CMCS. The resulting CDM-loaded composite hydrogels, (p)-MCM-41-CDM-CMCS, demonstrated slow degradation rates (about 70% remaining weight after 14-day immersion), while the CDM-free composite hydrogel entirely disintegrated after 4-day immersion. The plasma treatment was found to improve drug loading capacity and slow down initial drug burst effect. The prolonged releases of CDM from both (p)-MCM-41-CDM-CMCS retained their antibacterial effect against <i>Streptococcus sanguinis</i> for at least 14 days<i> in vitro.</i> <i>In vitro</i> assessment of osteogenic activity showed that the CDM-incorporated composite hydrogel was cytocompatible to human mesenchymal stem cells (hMSCs) and induced hMSC mineralization via p38-dependent upregulated alkaline phosphatase activity. In conclusion, novel (p)-MCM-41-CDM-CMCS hydrogels with combined controlled release of CDM and osteogenic potency were successfully developed for the first time, suggesting their potential clinical benefit for treatments of intraoral bone infection.</p>
Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris
ClinicalTrials.gov study NCT05926869. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota
ClinicalTrials.gov study NCT05166746. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis
ClinicalTrials.gov study NCT03234517. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Interest of High-dose Gentamicin Cement Associated With Clindamycin in Changes of Hip and Knee Prostheses
ClinicalTrials.gov study NCT06183606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris
ClinicalTrials.gov study NCT01796665. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)
ClinicalTrials.gov study NCT07267013. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.
ClinicalTrials.gov study NCT06673641. IPD Sharing: NO. Countries: 1. Publications: 0.
Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
ClinicalTrials.gov study NCT07335627. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo
ClinicalTrials.gov study NCT01257906. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Different Oral Doses of Clindamycin in Preventing Post-operative Sequelae of Lower Third Molar Surgery
ClinicalTrials.gov study NCT05268835. IPD Sharing: YES. Countries: 1. Publications: 0.
Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections
ClinicalTrials.gov study NCT02782078. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate
ClinicalTrials.gov study NCT00838812. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
ClinicalTrials.gov study NCT01361269. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis
ClinicalTrials.gov study NCT00889356. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
ClinicalTrials.gov study NCT07205107. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne
ClinicalTrials.gov study NCT02593383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children
ClinicalTrials.gov study NCT01464138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.